ESR1 and breast carcinoma: Therefore, the HIF-1/EZH2 signaling can be sustained inside extremely aggressive breast cancer cells devoid of the estrogen receptor (ER−), leading to the proliferation, invasion, migration, and angiogenesis of breast cancer cells [46].